Raymond James Financial Inc. Takes Position in Option Care Health, Inc. (NASDAQ:OPCH)

Raymond James Financial Inc. bought a new stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) during the 4th quarter, according to its most recent filing with the SEC. The firm bought 87,355 shares of the company’s stock, valued at approximately $2,027,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of OPCH. FMR LLC lifted its holdings in Option Care Health by 134.0% in the 3rd quarter. FMR LLC now owns 7,516,448 shares of the company’s stock worth $235,265,000 after buying an additional 4,304,896 shares in the last quarter. Wellington Management Group LLP lifted its stake in shares of Option Care Health by 15.5% in the third quarter. Wellington Management Group LLP now owns 9,924,915 shares of the company’s stock worth $310,650,000 after acquiring an additional 1,328,326 shares in the last quarter. Victory Capital Management Inc. lifted its stake in shares of Option Care Health by 31.1% in the fourth quarter. Victory Capital Management Inc. now owns 2,125,433 shares of the company’s stock worth $49,310,000 after acquiring an additional 503,840 shares in the last quarter. Bellevue Group AG boosted its holdings in Option Care Health by 16.8% in the third quarter. Bellevue Group AG now owns 1,654,878 shares of the company’s stock valued at $51,798,000 after purchasing an additional 237,999 shares during the last quarter. Finally, Villere ST Denis J & Co. LLC grew its stake in Option Care Health by 18.5% during the 4th quarter. Villere ST Denis J & Co. LLC now owns 1,344,608 shares of the company’s stock valued at $31,195,000 after purchasing an additional 209,502 shares in the last quarter. 98.05% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of brokerages have issued reports on OPCH. UBS Group initiated coverage on Option Care Health in a research report on Thursday, December 5th. They issued a “neutral” rating and a $26.00 target price on the stock. Jefferies Financial Group raised shares of Option Care Health from a “hold” rating to a “buy” rating and upped their price target for the company from $26.00 to $35.00 in a report on Thursday, January 23rd. Barrington Research raised their price objective on shares of Option Care Health from $33.00 to $38.00 and gave the stock an “outperform” rating in a report on Thursday, February 27th. JMP Securities restated a “market outperform” rating and issued a $30.00 target price (down previously from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. Finally, Bank of America upgraded Option Care Health from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $26.00 to $33.00 in a research note on Monday, January 13th. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $33.00.

Option Care Health Stock Down 1.3 %

Shares of NASDAQ:OPCH opened at $34.73 on Monday. The company’s fifty day moving average is $32.47 and its two-hundred day moving average is $28.38. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $35.53. The stock has a market capitalization of $5.70 billion, a price-to-earnings ratio of 29.18, a price-to-earnings-growth ratio of 2.30 and a beta of 1.33.

Insider Activity at Option Care Health

In related news, insider Michael Bavaro sold 30,996 shares of the firm’s stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the sale, the insider now owns 44,974 shares of the company’s stock, valued at approximately $1,495,835.24. This trade represents a 40.80 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 0.64% of the company’s stock.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.